Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of cyclosporine and tacrolimus in immunosuppressive regimens for kidney transplantation
IRCT201105166500N1Phase 2Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- May 2011
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of cyclosporine and tacrolimus in kidney allograft rejection (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: survival of transplanted kidney. Started May 2011; status: completed.
02
Drugs
cyclosporinetacrolimus
03
Conditions
kidney allograft rejection
Beyond the preview
Go deeper on IRCT201105166500N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201105166500N1.